Dr. Grivas on the Future of Molecular Subtyping in Urothelial Cancer

preview_player
Показать описание
Petros Grivas, MD, PhD, physician of the Seattle Cancer Care Alliance; associate professor in the Department of Medicine in the Division of Oncology and clinical director of the Genitourinary Cancers Program at the University of Washington School of Medicine; and associate member of the Clinical Research Division at Fred Hutchinson Cancer Center, discusses the future of molecular subtyping in urothelial cancer.
Рекомендации по теме
join shbcf.ru